US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Context Therapeutics Inc.

0.6602

+0.00891.37%

Post-market: 0.67960.0194+2.94%19:23 EDT

Volume:87.37K

Turnover:56.09K

Market Cap:59.22M

PE:-1.87

High:0.6602

Open:0.6520

Low:0.6305

Close:0.6513

Loading ...

Overview Company News Filings

Context Therapeutics Inc. Conducted Annual Stockholders Meeting

Alex C. Levit, Chief Legal Officer, Reports Acquisition of Common Shares in Context Therapeutics Inc

CFO Jennifer Lynn Minai-Azary Acquires Common Shares of Context Therapeutics Inc

Context Therapeutics Inc. Files Initial Statement of Beneficial Ownership for Chief Medical Officer Karen Deborah Chagin

Citizens JMP Remains a Buy on Context Therapeutics (CNTX)

Context Therapeutics Highlights T Cell Engager Advancements

Context Therapeutics Announces Phase 1 Trial of CTIM-76 for Advanced Solid Tumors at 2025 ASCO Meeting

Context Therapeutics Appoints Dr. Karen Chagin as Chief Medical Officer, Effective June 9, 2025

Context Therapeutics to Appoint DR. Karen Chagin, M.d. as Chief Medical Officer

THOMSON REUTERS

Context Therapeutics Inc. Announces New Stock Option Awards to Induce Employment

Context Therapeutics Inc. Q1 Net Income USD -4.6 Million

THOMSON REUTERS

Context Therapeutics: Co Expects Its Cash and Cash Equivalents Will Continue to Fund Operations Into 2027

THOMSON REUTERS

Press Release: Context Therapeutics Reports First Quarter 2025 Operating and Financial Results

Calendar of U.S. Earnings Expected in the Week Ahead

Press Release: Context Therapeutics Announces Chief Medical Officer Transition

Context Therapeutics presents preclinical data on CT-95

Context Therapeutics Presents Preclinical and Translational Data for CT-95, a Mesothelin Targeting T Cell Engager, at 2025 AACR Annual Meeting

Context Therapeutics Initiated at Outperform by William Blair

William Blair Initiates Context Therapeutics at Outperform

MT Newswires Live

Bet on These 5 Top-Ranked Stocks With Rising P/E

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CNTX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CNTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CNTX\",,,,,undefined,":{"symbol":"CNTX","market":"US","secType":"STK","nameCN":"Context Therapeutics Inc.","latestPrice":0.6602,"timestamp":1751054400000,"preClose":0.6513,"halted":0,"volume":87366,"hourTrading":{"tag":"盘后","latestPrice":0.6796,"preClose":0.6602,"latestTime":"19:23 EDT","volume":1578,"amount":1063.0869,"timestamp":1751066580986},"delay":0,"floatShares":39385370,"shares":89704194,"eps":-0.353286,"marketStatus":"Market Closed","change":0.0089,"latestTime":"06-27 16:00:00 EDT","open":0.652,"high":0.6602,"low":0.6305,"amount":56091.61394784,"amplitude":0.045601,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.353286,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1751270400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1634702400000,"exchange":"NASDAQ","adjPreClose":0.6513,"preHourTrading":{"tag":"盘前","latestPrice":0.6213,"preClose":0.6513,"latestTime":"09:26 EDT","volume":862,"amount":535.8501027,"timestamp":1751030781928},"postHourTrading":{"tag":"盘后","latestPrice":0.6796,"preClose":0.6602,"latestTime":"19:23 EDT","volume":1578,"amount":1063.0869,"timestamp":1751066580986},"volumeRatio":0.4920414826255185},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CNTX\",,,,,undefined,":{"symbol":"CNTX","floatShares":39385370,"roa":"-38.01%","roe":"-55.59%","lyrEps":-0.457495,"volumeRatio":0.4920414826255185,"shares":89704194,"dividePrice":0,"high":0.6602,"amplitude":0.045601,"preClose":0.6513,"low":0.6305,"week52Low":0.49,"pbRate":"0.65","week52High":2.75,"institutionHeld":0,"latestPrice":0.6602,"eps":-0.353286,"divideRate":0,"volume":87366,"delay":0,"ttmEps":-0.353286,"open":0.652,"prevYearClose":1.05,"prevWeekClose":0.5726,"prevMonthClose":0.5771,"prevQuarterClose":0.612,"fiveDayClose":0.5726,"twentyDayClose":0.6172,"sixtyDayClose":0.5511},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CNTX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2543754069","title":"Context Therapeutics Inc. Conducted Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2543754069","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543754069?lang=en_us&edition=fundamental","pubTime":"2025-06-13 05:15","pubTimestamp":1749762915,"startTime":"0","endTime":"0","summary":"Context Therapeutics Inc. held its 2025 Annual Meeting of Stockholders on June 12, 2025. At the meeting, stockholders ratified the appointment of CohnReznick LLP as the independent registered public accounting firm for the year ending December 31, 2025. Additionally, stockholders approved an amendment to the Amended and Restated Certificate of Incorporation to effect a reverse stock split of the outstanding common stock at a ratio ranging from 1-for-5 to 1-for-50, as determined by the Board of Directors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Context Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Secu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250612:nNDL2rgtdT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTX","BK4007"],"gpt_icon":0},{"id":"2542328650","title":"Alex C. Levit, Chief Legal Officer, Reports Acquisition of Common Shares in Context Therapeutics Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2542328650","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542328650?lang=en_us&edition=fundamental","pubTime":"2025-06-11 05:24","pubTimestamp":1749590663,"startTime":"0","endTime":"0","summary":"Alex C. Levit, Chief Legal Officer and Corporate Secretary, reported an acquisition of common shares of Context Therapeutics Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Context Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 10, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250610:nNDL5l4qdD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Alex C. Levit, Chief Legal Officer, Reports Acquisition of Common Shares in Context Therapeutics Inc","news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTX","BK4007"],"gpt_icon":0},{"id":"2542232850","title":"CFO Jennifer Lynn Minai-Azary Acquires Common Shares of Context Therapeutics Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2542232850","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542232850?lang=en_us&edition=fundamental","pubTime":"2025-06-11 05:22","pubTimestamp":1749590564,"startTime":"0","endTime":"0","summary":"Jennifer Lynn Minai-Azary, the Chief Financial Officer of Context Therapeutics Inc., reported an acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Context Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 10, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250610:nNDL8GnL3j:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTX","BK4007"],"gpt_icon":0},{"id":"2542358321","title":"Context Therapeutics Inc. Files Initial Statement of Beneficial Ownership for Chief Medical Officer Karen Deborah Chagin","url":"https://stock-news.laohu8.com/highlight/detail?id=2542358321","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542358321?lang=en_us&edition=fundamental","pubTime":"2025-06-10 05:14","pubTimestamp":1749503658,"startTime":"0","endTime":"0","summary":"Context Therapeutics Inc. has filed an initial statement of beneficial ownership with the United States Securities and Exchange Commission. The filing identifies Karen Deborah Chagin as the beneficial owner, serving as the Chief Medical Officer of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Context Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 09, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250609:nNDL1lNxRn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTX","BK4007"],"gpt_icon":0},{"id":"2540776461","title":"Citizens JMP Remains a Buy on Context Therapeutics (CNTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2540776461","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540776461?lang=en_us&edition=fundamental","pubTime":"2025-06-03 19:37","pubTimestamp":1748950621,"startTime":"0","endTime":"0","summary":"In a report released today, Silvan Tuerkcan from Citizens JMP reiterated a Buy rating on Context Therapeutics (CNTX – Research Report), with a pric...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/citizens-jmp-remains-a-buy-on-context-therapeutics-cntx-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/citizens-jmp-remains-a-buy-on-context-therapeutics-cntx-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4127","BK4007","JMP","CNTX"],"gpt_icon":0},{"id":"2540476012","title":"Context Therapeutics Highlights T Cell Engager Advancements","url":"https://stock-news.laohu8.com/highlight/detail?id=2540476012","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540476012?lang=en_us&edition=fundamental","pubTime":"2025-06-02 19:59","pubTimestamp":1748865547,"startTime":"0","endTime":"0","summary":"An announcement from Context Therapeutics ( ($CNTX) ) is now available. On June 2, 2025, Context Therapeutics updated its corporate presentation to...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/context-therapeutics-highlights-t-cell-engager-advancements?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/context-therapeutics-highlights-t-cell-engager-advancements?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","LENZ","CNTX","BK4007"],"gpt_icon":0},{"id":"2540035767","title":"Context Therapeutics Announces Phase 1 Trial of CTIM-76 for Advanced Solid Tumors at 2025 ASCO Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2540035767","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540035767?lang=en_us&edition=fundamental","pubTime":"2025-06-02 19:30","pubTimestamp":1748863851,"startTime":"0","endTime":"0","summary":"Context Therapeutics Inc., a clinical-stage biopharmaceutical company, has announced the presentation of a Trial in Progress poster for its Phase 1 clinical trial of CTIM-76 at the 2025 American Society of Clinical Oncology  Annual Meeting. The trial focuses on CTIM-76, a Claudin 6 x CD3 T cell engager, and is being evaluated for its safety and efficacy in treating CLDN6-positive advanced or metastatic ovarian, endometrial, and testicular cancers. The study, which began dosing its first patient in January 2025, is currently in the dosing cohort 3 phase. It is an open-label, dose escalation and expansion study expected to enroll up to 70 patients. The company plans to share initial data in the first half of 2026. Presentation materials will be available on Context Therapeutics' website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for in","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nNDL2dlCsc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00BGHQF748.EUR","LU2095319765.USD","BK4007","IE00B64PRP62.GBP","LU2210150020.SGD","BK4588","BK4112","NDAQ","CNTX","IE00BKPKM429.USD","LU2210149790.SGD","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2539252214","title":"Context Therapeutics Appoints Dr. Karen Chagin as Chief Medical Officer, Effective June 9, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2539252214","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539252214?lang=en_us&edition=fundamental","pubTime":"2025-05-29 19:30","pubTimestamp":1748518235,"startTime":"0","endTime":"0","summary":"Context Therapeutics Inc., a clinical-stage biopharmaceutical company, has appointed Dr. Karen Chagin as Chief Medical Officer, effective June 9, 2025. Dr. Chagin, who has extensive experience in T cell therapies for solid tumors, previously held a senior position at Adaptimmune Therapeutics. She succeeds Dr. Karen Smith, who will remain on the company's Board of Directors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Context Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on May 29, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250529:nNDL1f2YFK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","BK4139","ADAP","CNTX","NDAQ","IE00BGHQF748.EUR","BK4112","IE00B3QW5Z07.USD","LU2095319765.USD","IE00B64PRP62.GBP","IE00BKPKM429.USD","BK4585","BK4588","BK4007","LU2210149790.SGD"],"gpt_icon":0},{"id":"2539252267","title":"Context Therapeutics to Appoint DR. Karen Chagin, M.d. as Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2539252267","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539252267?lang=en_us&edition=fundamental","pubTime":"2025-05-29 19:30","pubTimestamp":1748518205,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250529:nTUA9P0K66:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CNTX"],"gpt_icon":0},{"id":"2535257784","title":"Context Therapeutics Inc. Announces New Stock Option Awards to Induce Employment","url":"https://stock-news.laohu8.com/highlight/detail?id=2535257784","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535257784?lang=en_us&edition=fundamental","pubTime":"2025-05-13 04:38","pubTimestamp":1747082309,"startTime":"0","endTime":"0","summary":"Context Therapeutics Inc., a clinical-stage biopharmaceutical company, has announced the issuance of non-qualified stock option awards as part of its compensation strategy. On May 12, 2025, the company granted options to purchase a total of 160,000 shares of common stock to two newly hired employees. These options, issued outside of the 2021 Long-Term Performance Incentive Plan, are aligned with Nasdaq Listing Rule 5635. The exercise prices are set at $0.839 and $0.78 per share, corresponding to the closing prices on the respective grant dates of May 5 and May 12, 2025. The stock options come with a 10-year term and a four-year vesting schedule, beginning with one-fourth of the shares vesting after the first year, followed by monthly installments, contingent on the employees' continued service with the company.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-g","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250512:nNDL1bGy7C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","LU2095319765.USD","IE00BKPKM429.USD","IE00B64PRP62.GBP","BK4585","IE00BGHQF748.EUR","LU2210150020.SGD","LU2210149790.SGD","NDAQ","BK4112","BK4007","CNTX","BK4588"],"gpt_icon":0},{"id":"2533966202","title":"Context Therapeutics Inc. Q1 Net Income USD -4.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2533966202","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533966202?lang=en_us&edition=fundamental","pubTime":"2025-05-08 04:09","pubTimestamp":1746648597,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250507:nPLX803F9B:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CNTX","BK4007"],"gpt_icon":0},{"id":"2533960926","title":"Context Therapeutics: Co Expects Its Cash and Cash Equivalents Will Continue to Fund Operations Into 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2533960926","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533960926?lang=en_us&edition=fundamental","pubTime":"2025-05-08 04:09","pubTimestamp":1746648597,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250507:nPLX803F9B:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CNTX","BK4007"],"gpt_icon":0},{"id":"2533579969","title":"Press Release: Context Therapeutics Reports First Quarter 2025 Operating and Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2533579969","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533579969?lang=en_us&edition=fundamental","pubTime":"2025-05-08 04:09","pubTimestamp":1746648540,"startTime":"0","endTime":"0","summary":"Cash and cash equivalents of $89.4 million as of March 31, 2025. Company expects its cash and cash equivalents will continue to fund operations into 2027. PHILADELPHIA, May 07, 2025  -- Context Therapeutics Inc.  , a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today announced its financial results for the first quarter ended March 31, 2025, and reported on recent and upcoming business highlights.-- In May 2025, announced Context board member, Dr. Karen Smith, to serve as. Interim Chief Medical Officer in connection with Dr. Claudio Dansky. -- In April 2025, presented preclinical and translational data for CT-95, a. MSLN targeting T cell engager, at the American Association for Cancer. trial evaluating CT-95 in patients with MSLN-expressing advanced solid. tumors, including ovarian, pancreatic, lung, and mesothelioma cancers.-- In January 2025, announced the first patient dosed in our Phase 1 trial. evaluating CTIM-76 in pat","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTX","LENZ"],"gpt_icon":0},{"id":"2533609942","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2533609942","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533609942?lang=en_us&edition=fundamental","pubTime":"2025-05-07 18:00","pubTimestamp":1746612000,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·A-Mark Prcs Mtls                                 3Q       .55    4:05 PM. ·Alpha and Omega                                  3Q      (.17)   4:01 PM. ·Ares Cmm. Rl Est                                 1Q       .00    6:00 AM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TECH","ACRE","BTMD","AMRK","DIN","AIRG","ALTG","TKNO","BV","BWA","AVDX","CLF","CNTX","BSY","CXW","CLRB","BYND","BLBD","BLZE","EPC","AVA","AOSL","RNAC","CPRX","CTRI","DFH","DHX","CSGS","AVDL","APA","ADNT","AXON","BRKR","CMTG","BLMN","CING","ASLE","BBSI","CRNC","DAY","BAND","BDTX","BLTE","CVNA","GOLF","CF","CIVI","CW","CPK"],"gpt_icon":1},{"id":"2533755029","title":"Press Release: Context Therapeutics Announces Chief Medical Officer Transition","url":"https://stock-news.laohu8.com/highlight/detail?id=2533755029","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533755029?lang=en_us&edition=fundamental","pubTime":"2025-05-06 04:05","pubTimestamp":1746475500,"startTime":"0","endTime":"0","summary":"Board Member Dr. Karen Smith to serve as Interim Chief Medical Officer. Dr. Smith has served on Context's Board since 2024 and is a biopharmaceutical thought leader with over 20 years of experience bringing drugs into the clinic and through commercialization. She was previously Global Head of Research & Development and Chief Medical Officer of Jazz Pharmaceuticals and has also held senior leadership roles at Allergan, AstraZeneca, and Bristol Myers Squibb.\"As we take the next steps in advancing our pipeline, I am delighted to have Karen's support and leadership. Karen's experience in drug development will make her guidance invaluable through this transition,\" said Martin Lehr, CEO of Context. \"I am grateful to Claudio for his contributions to Context.\"","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","LENZ","BK4232","BK4022","CNTX","BK4139","BK4007"],"gpt_icon":0},{"id":"2531036186","title":"Context Therapeutics presents preclinical data on CT-95","url":"https://stock-news.laohu8.com/highlight/detail?id=2531036186","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531036186?lang=en_us&edition=fundamental","pubTime":"2025-04-30 19:38","pubTimestamp":1746013116,"startTime":"0","endTime":"0","summary":"Context Therapeutics (CNTX) announced preclinical and translational data regarding the Company’s clinical asset, CT-95, a mesothelin x CD3 TCE was ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/context-therapeutics-presents-preclinical-data-on-ct-95?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/context-therapeutics-presents-preclinical-data-on-ct-95?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CNTX","LENZ","BK4007"],"gpt_icon":0},{"id":"2531035701","title":"Context Therapeutics Presents Preclinical and Translational Data for CT-95, a Mesothelin Targeting T Cell Engager, at 2025 AACR Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2531035701","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531035701?lang=en_us&edition=fundamental","pubTime":"2025-04-30 19:30","pubTimestamp":1746012600,"startTime":"0","endTime":"0","summary":"Preclinical data demonstrates unique binding location of CT-95 on mesothelin and avoidance of binding to shed mesothelin. Data supports ongoing Phase 1 clinical trial for CT-95. PHILADELPHIA, April 30, 2025  -- Context Therapeutics Inc.  , a clinical-stage biopharmaceutical company advancing T cell engaging  bispecific antibodies for solid tumors, today announced preclinical and translational data regarding the Company’s clinical asset, CT-95, a mesothelin x CD3 TCE was presented at the American Association for Cancer Research  Annual Meeting 2025, taking place April 25-30, 2025 in Chicago, IL.Findings from preclinical studies evaluating CT-95 in cancer cell lines and tumor models illustrate the potential of CT-95 to treat mesothelin-positive tumors. Notably, CT-95 has shown to:. Activate T cells without inducing broad cytokine release","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/context-therapeutics-presents-preclinical-translational-113000360.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","LENZ","CNTX","BK4139"],"gpt_icon":0},{"id":"2529381115","title":"Context Therapeutics Initiated at Outperform by William Blair","url":"https://stock-news.laohu8.com/highlight/detail?id=2529381115","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529381115?lang=en_us&edition=fundamental","pubTime":"2025-04-21 23:36","pubTimestamp":1745249760,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CNTX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 21, 2025 11:36 ET (15:36 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTX","LENZ"],"gpt_icon":0},{"id":"2529709858","title":"William Blair Initiates Context Therapeutics at Outperform","url":"https://stock-news.laohu8.com/highlight/detail?id=2529709858","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529709858?lang=en_us&edition=fundamental","pubTime":"2025-04-21 19:47","pubTimestamp":1745236067,"startTime":"0","endTime":"0","summary":"Context Therapeutics (CNTX) has an average rating of buy and mean price target of $5.50, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","CNTX"],"gpt_icon":0},{"id":"2529202801","title":"Bet on These 5 Top-Ranked Stocks With Rising P/E","url":"https://stock-news.laohu8.com/highlight/detail?id=2529202801","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529202801?lang=en_us&edition=fundamental","pubTime":"2025-04-21 19:40","pubTimestamp":1745235600,"startTime":"0","endTime":"0","summary":"Investors often opt for the stock-picking approach that involves stocks with a low price-to-earnings (P/E) ratio. This strategy is based on the notion that the lower the P/E ratio is, the higher the stock value. The reasoning behind this is straightforward — when a stock's current market price does not adequately reflect its higher earnings, it suggests potential for growth.But there is more to this whole P/E story. Because not only low P/E, stocks with a rising P/E can also fetch strong returns. In this regard, investors can bet on the likes of Carvana CVNA, Context Therapeutics Inc. CNTX, Inovio Pharmaceuticals INO, ChargePoint CHPT and MSA Safety Incorporporated MSA.The concept isthat as earnings rise, so should the price of the stock. As forecasts for expected earnings come in higher, strong demand for the stock should continue to push up its prices. After all, a stock's P/E gives an indication of how much investors are ready to shell out per dollar of earnings.Percentage price cha","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bet-5-top-ranked-stocks-114000310.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1923622291.USD","SPXU","SSO","BK4551","BK4139","LU1815336091.USD","BK4143","CHPT","BK4588","BK4534","MSA","BK4503","BK4542","LU2125909759.SGD","BK4559","BK4550","OEX","SH","BK4007","BK4568","BK4585","LU0053671581.USD","CNTX","CVNA",".SPX","LU0757428866.USD","BK4214","BK4581","ESmain","BK4583","SDS","SPY","LU2125909916.SGD","INO","VOO","BK4504","IVV","LU2211815571.USD","LU0728928796.USD","OEF","BK4548","BK4096"],"gpt_icon":1}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":47,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CNTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-07","symbol":"CNTX","fiscalQuarterEnding":"2025/03","expectedEps":-0.05,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"post","actualEps":-0.05}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CNTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CNTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1667,"buy":0.8333,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8333,"analysts":6,"updateTime":1745294400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CNTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CNTX","date":"2025-06-27","current":-2.114176,"percent":0.501669,"low":-12.262263,"twenty":-4.142246,"median":-2.121967,"eighty":-0.863916,"high":18.148289,"avg":-2.716218,"sd":3.265191,"marketCap":58424341},"quantilePoints":[{"date":"2021-07-29","current":17.91077,"twenty":17.91077,"median":17.91077,"eighty":17.91077,"marketCap":88227308},{"date":"2021-08-05","current":18.148289,"twenty":17.91077,"median":18.029529,"eighty":18.148289,"marketCap":89397308},{"date":"2021-10-22","current":-10.102458,"twenty":-6.812632,"median":17.91077,"eighty":18.148289,"marketCap":76608946},{"date":"2021-10-29","current":-8.324772,"twenty":-9.37404,"median":-6.73185,"eighty":18.053281,"marketCap":63128401},{"date":"2021-11-05","current":-7.956227,"twenty":-8.79015,"median":-7.89119,"eighty":17.91077,"marketCap":60333654},{"date":"2021-11-12","current":-7.818926,"twenty":-8.567578,"median":-7.923709,"eighty":17.91077,"marketCap":59292474},{"date":"2021-11-19","current":-7.067384,"twenty":-8.414378,"median":-7.558777,"eighty":17.91077,"marketCap":53593382},{"date":"2021-11-26","current":-7.370892,"twenty":-8.347896,"median":-7.486514,"eighty":13.042323,"marketCap":55894939},{"date":"2021-12-03","current":-7.130156,"twenty":-8.434612,"median":-7.544325,"eighty":-6.491541,"marketCap":58109019},{"date":"2021-12-10","current":-10.538494,"twenty":-9.837551,"median":-7.818926,"eighty":-6.73185,"marketCap":85886137},{"date":"2021-12-17","current":-5.817719,"twenty":-9.53591,"median":-7.633709,"eighty":-6.469339,"marketCap":47412979},{"date":"2021-12-23","current":-6.307426,"twenty":-8.888428,"median":-7.508193,"eighty":-6.209485,"marketCap":51403970},{"date":"2021-12-31","current":-5.210482,"twenty":-8.642732,"median":-7.228075,"eighty":-5.680601,"marketCap":42464149},{"date":"2022-01-07","current":-4.955835,"twenty":-8.454846,"median":-7.113223,"eighty":-5.367189,"marketCap":40388833},{"date":"2022-01-14","current":-4.407363,"twenty":-8.353677,"median":-7.067384,"eighty":-4.995011,"marketCap":35918923},{"date":"2022-01-21","current":-4.113539,"twenty":-8.330553,"median":-6.866487,"eighty":-4.850058,"marketCap":33524328},{"date":"2022-01-28","current":-3.800126,"twenty":-8.310637,"median":-6.676344,"eighty":-4.403445,"marketCap":30970094},{"date":"2022-02-04","current":-4.368186,"twenty":-8.164729,"median":-6.346602,"eighty":-4.321174,"marketCap":35599644},{"date":"2022-02-11","current":-3.839303,"twenty":-8.10065,"median":-6.170308,"eighty":-4.129209,"marketCap":31289373},{"date":"2022-02-18","current":-3.76095,"twenty":-8.081966,"median":-5.817719,"eighty":-4.031267,"marketCap":30650814},{"date":"2022-02-25","current":-3.506302,"twenty":-8.070404,"median":-5.523895,"eighty":-3.937244,"marketCap":28575499},{"date":"2022-03-04","current":-3.741361,"twenty":-7.999585,"median":-5.406365,"eighty":-3.831467,"marketCap":30491175},{"date":"2022-03-11","current":-3.565067,"twenty":-7.956227,"median":-5.210482,"eighty":-3.800126,"marketCap":29054418},{"date":"2022-03-18","current":-4.113539,"twenty":-7.917205,"median":-4.985217,"eighty":-3.753114,"marketCap":33524328},{"date":"2022-03-25","current":-3.435408,"twenty":-7.847832,"median":-4.877482,"eighty":-3.682597,"marketCap":35923619},{"date":"2022-04-01","current":-3.664436,"twenty":-7.752755,"median":-4.642423,"eighty":-3.655173,"marketCap":38318527},{"date":"2022-04-08","current":-3.878194,"twenty":-7.618723,"median":-4.466128,"eighty":-3.663865,"marketCap":40553774},{"date":"2022-04-14","current":-2.748327,"twenty":-7.547215,"median":-4.387775,"eighty":-3.553314,"marketCap":28738895},{"date":"2022-04-22","current":-2.473494,"twenty":-7.512529,"median":-4.289833,"eighty":-3.506302,"marketCap":25865005},{"date":"2022-04-29","current":-2.21393,"twenty":-7.440265,"median":-4.191892,"eighty":-3.433942,"marketCap":23150776},{"date":"2022-05-06","current":-2.244467,"twenty":-7.313765,"median":-4.113539,"eighty":-3.331713,"marketCap":23470097},{"date":"2022-05-13","current":-1.780396,"twenty":-7.204267,"median":-4.113539,"eighty":-3.018579,"marketCap":23150776},{"date":"2022-05-20","current":-2.173312,"twenty":-7.153195,"median":-4.050461,"eighty":-2.580373,"marketCap":28259913},{"date":"2022-05-27","current":-2.517112,"twenty":-7.11661,"median":-4.015597,"eighty":-2.476207,"marketCap":32730408},{"date":"2022-06-03","current":-2.455719,"twenty":-7.093399,"median":-3.985074,"eighty":-2.47485,"marketCap":31932106},{"date":"2022-06-10","current":-2.345212,"twenty":-7.078946,"median":-3.937244,"eighty":-2.433295,"marketCap":30495161},{"date":"2022-06-17","current":-2.639898,"twenty":-7.04715,"median":-3.858891,"eighty":-2.430839,"marketCap":34327013},{"date":"2022-06-24","current":-2.578505,"twenty":-6.966215,"median":-3.839303,"eighty":-2.443441,"marketCap":33528711},{"date":"2022-07-01","current":-2.529391,"twenty":-6.866487,"median":-3.819714,"eighty":-2.455719,"marketCap":32890069},{"date":"2022-07-08","current":-2.517112,"twenty":-6.758777,"median":-3.800126,"eighty":-2.443441,"marketCap":32730408},{"date":"2022-07-15","current":-2.406605,"twenty":-6.73185,"median":-3.76095,"eighty":-2.406605,"marketCap":31293463},{"date":"2022-07-22","current":-2.406605,"twenty":-6.64304,"median":-3.682597,"eighty":-2.404149,"marketCap":31293463},{"date":"2022-07-29","current":-2.320532,"twenty":-6.469339,"median":-3.664436,"eighty":-2.369769,"marketCap":30174243},{"date":"2022-08-05","current":-2.35749,"twenty":-6.363574,"median":-3.604243,"eighty":-2.35749,"marketCap":30654821},{"date":"2022-08-12","current":-2.616619,"twenty":-6.315261,"median":-3.545479,"eighty":-2.35749,"marketCap":31293463},{"date":"2022-08-19","current":-2.443067,"twenty":-6.229073,"median":-3.506302,"eighty":-2.35749,"marketCap":29217876},{"date":"2022-08-26","current":-2.563218,"twenty":-6.146802,"median":-3.465945,"eighty":-2.367313,"marketCap":30654821},{"date":"2022-09-02","current":-2.509818,"twenty":-6.115461,"median":-3.420663,"eighty":-2.369769,"marketCap":30016179},{"date":"2022-09-09","current":-2.429717,"twenty":-5.935249,"median":-3.364287,"eighty":-2.369769,"marketCap":29058216},{"date":"2022-09-16","current":-1.935764,"twenty":-5.735448,"median":-3.297992,"eighty":-2.35749,"marketCap":23150776},{"date":"2022-09-23","current":-1.628712,"twenty":-5.586577,"median":-3.019342,"eighty":-2.345212,"marketCap":19478584},{"date":"2022-09-30","current":-1.48186,"twenty":-5.523895,"median":-2.873192,"eighty":-2.332933,"marketCap":17722318},{"date":"2022-10-07","current":-1.548611,"twenty":-5.476883,"median":-2.756545,"eighty":-2.310806,"marketCap":18520621},{"date":"2022-10-14","current":-1.45516,"twenty":-5.39853,"median":-2.738127,"eighty":-2.27154,"marketCap":17402997},{"date":"2022-10-21","current":-1.40176,"twenty":-5.367189,"median":-2.70568,"eighty":-2.223091,"marketCap":16764355},{"date":"2022-10-28","current":-1.682112,"twenty":-5.273165,"median":-2.676734,"eighty":-2.198661,"marketCap":20117226},{"date":"2022-11-04","current":-1.561961,"twenty":-5.092952,"median":-2.639898,"eighty":-2.080175,"marketCap":18680282},{"date":"2022-11-11","current":-1.366517,"twenty":-5.002846,"median":-2.623294,"eighty":-2.004621,"marketCap":19638245},{"date":"2022-11-18","current":-1.377627,"twenty":-4.983258,"median":-2.61598,"eighty":-1.849366,"marketCap":19797905},{"date":"2022-11-25","current":-1.522055,"twenty":-4.967588,"median":-2.591717,"eighty":-1.771096,"marketCap":21873492},{"date":"2022-12-02","current":-1.533165,"twenty":-4.924494,"median":-2.578505,"eighty":-1.687046,"marketCap":22033153},{"date":"2022-12-09","current":-0.92201,"twenty":-4.822635,"median":-2.563218,"eighty":-1.644732,"marketCap":13250227},{"date":"2022-12-16","current":-0.821799,"twenty":-4.716858,"median":-2.549868,"eighty":-1.594001,"marketCap":11810089},{"date":"2022-12-23","current":-0.699923,"twenty":-4.650258,"median":-2.532954,"eighty":-1.566974,"marketCap":10058613},{"date":"2022-12-30","current":-0.724032,"twenty":-4.599328,"median":-2.52628,"eighty":-1.5567,"marketCap":10405076},{"date":"2023-01-06","current":-0.866572,"twenty":-4.583657,"median":-2.52014,"eighty":-1.544275,"marketCap":12453521},{"date":"2023-01-13","current":-0.814355,"twenty":-4.466128,"median":-2.509818,"eighty":-1.533165,"marketCap":11703116},{"date":"2023-01-20","current":-0.770471,"twenty":-4.419116,"median":-2.496468,"eighty":-1.519241,"marketCap":11072457},{"date":"2023-01-27","current":-0.777693,"twenty":-4.391693,"median":-2.473494,"eighty":-1.48186,"marketCap":11176237},{"date":"2023-02-03","current":-1.013222,"twenty":-4.372104,"median":-2.455719,"eighty":-1.464106,"marketCap":14561040},{"date":"2023-02-10","current":-0.944341,"twenty":-4.352516,"median":-2.455719,"eighty":-1.42846,"marketCap":13571145},{"date":"2023-02-17","current":-0.919455,"twenty":-4.254574,"median":-2.443441,"eighty":-1.410452,"marketCap":13213505},{"date":"2023-02-24","current":-0.855684,"twenty":-4.219315,"median":-2.443067,"eighty":-1.384097,"marketCap":12297054},{"date":"2023-03-03","current":-0.844352,"twenty":-4.199727,"median":-2.428703,"eighty":-1.333187,"marketCap":12134200},{"date":"2023-03-10","current":-0.76636,"twenty":-4.156633,"median":-2.406605,"eighty":-1.284304,"marketCap":11013383},{"date":"2023-03-17","current":-0.687147,"twenty":-4.121374,"median":-2.404811,"eighty":-1.103212,"marketCap":9875003},{"date":"2023-03-24","current":-0.667228,"twenty":-4.113539,"median":-2.394326,"eighty":-1.018621,"marketCap":9898952},{"date":"2023-03-31","current":-0.605025,"twenty":-4.113539,"median":-2.375908,"eighty":-0.939008,"marketCap":8976114},{"date":"2023-04-06","current":-0.641077,"twenty":-4.113539,"median":-2.369769,"eighty":-0.925499,"marketCap":9510977},{"date":"2023-04-14","current":-0.634943,"twenty":-4.09269,"median":-2.35749,"eighty":-0.904345,"marketCap":9419971},{"date":"2023-04-21","current":-0.661955,"twenty":-4.058759,"median":-2.351351,"eighty":-0.873505,"marketCap":9820719},{"date":"2023-04-28","current":-0.624289,"twenty":-4.051324,"median":-2.345212,"eighty":-0.859195,"marketCap":9261907},{"date":"2023-05-05","current":-0.518716,"twenty":-4.041763,"median":-2.332933,"eighty":-0.846685,"marketCap":7695637},{"date":"2023-05-12","current":-0.523457,"twenty":-4.02735,"median":-2.320655,"eighty":-0.844352,"marketCap":9268293},{"date":"2023-05-19","current":-0.504972,"twenty":-4.007762,"median":-2.28561,"eighty":-0.821977,"marketCap":8940989},{"date":"2023-05-26","current":-0.757458,"twenty":-3.991635,"median":-2.27154,"eighty":-0.808066,"marketCap":13411484},{"date":"2023-06-02","current":-0.955839,"twenty":-3.978967,"median":-2.27154,"eighty":-0.8074,"marketCap":16924016},{"date":"2023-06-09","current":-1.181273,"twenty":-3.951078,"median":-2.221564,"eighty":-0.807822,"marketCap":20915529},{"date":"2023-06-16","current":-1.100117,"twenty":-3.937244,"median":-2.206296,"eighty":-0.809267,"marketCap":19478584},{"date":"2023-06-23","current":-1.199308,"twenty":-3.937244,"median":-2.198661,"eighty":-0.810666,"marketCap":21234850},{"date":"2023-06-30","current":-1.253412,"twenty":-3.913624,"median":-2.173312,"eighty":-0.812422,"marketCap":22192813},{"date":"2023-07-06","current":-1.352603,"twenty":-3.890004,"median":-2.162715,"eighty":-0.813711,"marketCap":23949079},{"date":"2023-07-14","current":-1.109134,"twenty":-3.870473,"median":-2.079565,"eighty":-0.817333,"marketCap":19638245},{"date":"2023-07-21","current":-1.073065,"twenty":-3.866612,"median":-2.076514,"eighty":-0.818821,"marketCap":18999603},{"date":"2023-07-28","current":-1.000926,"twenty":-3.858891,"median":-2.056665,"eighty":-0.822065,"marketCap":17722318},{"date":"2023-08-04","current":-1.118152,"twenty":-3.847138,"median":-1.909064,"eighty":-0.825476,"marketCap":19797905},{"date":"2023-08-11","current":-0.886495,"twenty":-3.82755,"median":-1.848191,"eighty":-0.825476,"marketCap":16604695},{"date":"2023-08-18","current":-0.860923,"twenty":-3.819714,"median":-1.775563,"eighty":-0.83633,"marketCap":16125713},{"date":"2023-08-25","current":-0.903543,"twenty":-3.819714,"median":-1.739536,"eighty":-0.843463,"marketCap":16924016},{"date":"2023-09-01","current":-0.877971,"twenty":-3.807961,"median":-1.682112,"eighty":-0.844352,"marketCap":16445034},{"date":"2023-09-08","current":-0.788469,"twenty":-3.800126,"median":-1.682112,"eighty":-0.843019,"marketCap":14768599},{"date":"2023-09-15","current":-0.886495,"twenty":-3.784456,"median":-1.622037,"eighty":-0.843019,"marketCap":16604695},{"date":"2023-09-22","current":-0.835351,"twenty":-3.76095,"median":-1.602011,"eighty":-0.824693,"marketCap":15646731},{"date":"2023-09-29","current":-1.082547,"twenty":-3.753114,"median":-1.579625,"eighty":-0.824693,"marketCap":20276887},{"date":"2023-10-06","current":-1.108118,"twenty":-3.717855,"median":-1.561961,"eighty":-0.830719,"marketCap":20755868},{"date":"2023-10-13","current":-1.108118,"twenty":-3.682597,"median":-1.558673,"eighty":-0.837056,"marketCap":20755868},{"date":"2023-10-20","current":-1.074023,"twenty":-3.682597,"median":-1.548611,"eighty":-0.84062,"marketCap":20117226},{"date":"2023-10-27","current":-0.929115,"twenty":-3.682597,"median":-1.544275,"eighty":-0.841627,"marketCap":17402997},{"date":"2023-11-02","current":-0.946163,"twenty":-3.6717,"median":-1.535261,"eighty":-0.843463,"marketCap":17722318},{"date":"2023-11-10","current":-0.924853,"twenty":-3.663579,"median":-1.533165,"eighty":-0.844352,"marketCap":17323167},{"date":"2023-11-17","current":-0.777101,"twenty":-3.651255,"median":-1.521911,"eighty":-0.832263,"marketCap":16125713},{"date":"2023-11-24","current":-0.666384,"twenty":-3.612079,"median":-1.499836,"eighty":-0.821977,"marketCap":13828198},{"date":"2023-12-01","current":-0.653996,"twenty":-3.557232,"median":-1.48186,"eighty":-0.810321,"marketCap":13571145},{"date":"2023-12-08","current":-0.657843,"twenty":-3.545479,"median":-1.46851,"eighty":-0.807444,"marketCap":13650975},{"date":"2023-12-15","current":-0.64661,"twenty":-3.531988,"median":-1.455278,"eighty":-0.796618,"marketCap":13417870},{"date":"2023-12-22","current":-0.861736,"twenty":-3.509571,"median":-1.433759,"eighty":-0.787336,"marketCap":17881979},{"date":"2023-12-29","current":-0.884818,"twenty":-3.506302,"median":-1.42846,"eighty":-0.788469,"marketCap":18360960},{"date":"2024-01-05","current":-0.961759,"twenty":-3.506302,"median":-1.41511,"eighty":-0.790882,"marketCap":19957566},{"date":"2024-01-12","current":-0.900207,"twenty":-3.506302,"median":-1.409696,"eighty":-0.793112,"marketCap":18680282},{"date":"2024-01-19","current":-0.846348,"twenty":-3.490159,"median":-1.395085,"eighty":-0.796618,"marketCap":17562658},{"date":"2024-01-26","current":-0.708086,"twenty":-3.45373,"median":-1.366517,"eighty":-0.790077,"marketCap":14693558},{"date":"2024-02-02","current":-0.79249,"twenty":-3.434431,"median":-1.342895,"eighty":-0.787336,"marketCap":16445034},{"date":"2024-02-09","current":-0.761713,"twenty":-3.423123,"median":-1.325551,"eighty":-0.785065,"marketCap":15806392},{"date":"2024-02-16","current":-0.784795,"twenty":-3.39269,"median":-1.290581,"eighty":-0.785065,"marketCap":16285374},{"date":"2024-02-23","current":-0.900207,"twenty":-3.367225,"median":-1.28238,"eighty":-0.785691,"marketCap":18680282},{"date":"2024-03-01","current":-0.877124,"twenty":-3.350164,"median":-1.253412,"eighty":-0.786958,"marketCap":18201300},{"date":"2024-03-08","current":-0.884818,"twenty":-3.310207,"median":-1.217342,"eighty":-0.789273,"marketCap":18360960},{"date":"2024-03-15","current":-0.854042,"twenty":-3.27967,"median":-1.199308,"eighty":-0.79249,"marketCap":17722318},{"date":"2024-03-22","current":-0.712883,"twenty":-3.169737,"median":-1.179461,"eighty":-0.789273,"marketCap":17083676},{"date":"2024-03-28","current":-0.920752,"twenty":-3.023159,"median":-1.163239,"eighty":-0.788469,"marketCap":22065085},{"date":"2024-04-05","current":-0.852794,"twenty":-3.015525,"median":-1.154221,"eighty":-0.79249,"marketCap":20436547},{"date":"2024-04-12","current":-1.012693,"twenty":-3.007891,"median":-1.1392,"eighty":-0.79249,"marketCap":24268400},{"date":"2024-04-19","current":-0.939406,"twenty":-2.873192,"median":-1.13369,"eighty":-0.79249,"marketCap":22512134},{"date":"2024-04-26","current":-0.919419,"twenty":-2.77682,"median":-1.114571,"eighty":-0.79249,"marketCap":22033153},{"date":"2024-05-03","current":-1.16593,"twenty":-2.762684,"median":-1.109134,"eighty":-0.79249,"marketCap":27940592},{"date":"2024-05-10","current":-1.370207,"twenty":-2.750406,"median":-1.122661,"eighty":-0.793527,"marketCap":29217876},{"date":"2024-05-17","current":-1.347745,"twenty":-2.748327,"median":-1.13369,"eighty":-0.800107,"marketCap":28738895},{"date":"2024-05-24","current":-6.858415,"twenty":-2.762684,"median":-1.144078,"eighty":-0.801255,"marketCap":146246708},{"date":"2024-05-31","current":-7.034271,"twenty":-3.009418,"median":-1.15248,"eighty":-0.801255,"marketCap":149996624},{"date":"2024-06-07","current":-6.154988,"twenty":-3.301046,"median":-1.163239,"eighty":-0.803476,"marketCap":131247046},{"date":"2024-06-14","current":-6.928757,"twenty":-3.384855,"median":-1.16593,"eighty":-0.80569,"marketCap":147746674},{"date":"2024-06-21","current":-7.632185,"twenty":-3.45373,"median":-1.181273,"eighty":-0.80702,"marketCap":162746337},{"date":"2024-06-28","current":-7.069443,"twenty":-3.506302,"median":-1.184834,"eighty":-0.807244,"marketCap":150746607},{"date":"2024-07-05","current":-6.295673,"twenty":-3.525242,"median":-1.199308,"eighty":-0.807489,"marketCap":134246978},{"date":"2024-07-12","current":-7.104614,"twenty":-3.651255,"median":-1.207115,"eighty":-0.807758,"marketCap":151496590},{"date":"2024-07-15","current":-7.104614,"twenty":-3.663294,"median":-1.208325,"eighty":-0.807818,"marketCap":151496590},{"date":"2024-08-02","current":-7.843213,"twenty":-3.664436,"median":-1.217342,"eighty":-0.807878,"marketCap":167246235},{"date":"2024-08-09","current":-9.694467,"twenty":-3.741361,"median":-1.253412,"eighty":-0.807878,"marketCap":179995948},{"date":"2024-08-16","current":-10.7447,"twenty":-3.800126,"median":-1.260162,"eighty":-0.807878,"marketCap":199495509},{"date":"2024-08-23","current":-10.098403,"twenty":-3.839303,"median":-1.277638,"eighty":-0.8088,"marketCap":187495780},{"date":"2024-08-30","current":-9.896435,"twenty":-3.937244,"median":-1.287935,"eighty":-0.809779,"marketCap":183745864},{"date":"2024-09-06","current":-9.209743,"twenty":-3.987261,"median":-1.307246,"eighty":-0.810862,"marketCap":170996151},{"date":"2024-09-13","current":-8.684626,"twenty":-4.047873,"median":-1.333187,"eighty":-0.813711,"marketCap":161246370},{"date":"2024-09-20","current":-9.007775,"twenty":-4.113539,"median":-1.350174,"eighty":-0.815329,"marketCap":167246235},{"date":"2024-09-27","current":-7.472818,"twenty":-4.19581,"median":-1.366517,"eighty":-0.815572,"marketCap":138746877},{"date":"2024-10-04","current":-7.997935,"twenty":-4.372104,"median":-1.383018,"eighty":-0.81748,"marketCap":148496657},{"date":"2024-10-11","current":-6.907307,"twenty":-4.587575,"median":-1.40176,"eighty":-0.821031,"marketCap":128247113},{"date":"2024-10-18","current":-8.119116,"twenty":-4.893153,"median":-1.410956,"eighty":-0.822154,"marketCap":150746607},{"date":"2024-10-25","current":-9.492498,"twenty":-5.053776,"median":-1.42846,"eighty":-0.822637,"marketCap":176246033},{"date":"2024-10-31","current":-8.765414,"twenty":-5.39853,"median":-1.433759,"eighty":-0.824781,"marketCap":162746337},{"date":"2024-11-08","current":-5.198529,"twenty":-5.586577,"median":-1.455278,"eighty":-0.826726,"marketCap":156746472},{"date":"2024-11-15","current":-4.725935,"twenty":-5.523895,"median":-1.46851,"eighty":-0.827424,"marketCap":142496792},{"date":"2024-11-22","current":-3.731002,"twenty":-5.476883,"median":-1.48186,"eighty":-0.829628,"marketCap":112497468},{"date":"2024-11-29","current":-3.780748,"twenty":-5.414201,"median":-1.492609,"eighty":-0.832716,"marketCap":113997434},{"date":"2024-12-06","current":-3.731002,"twenty":-5.367189,"median":-1.499836,"eighty":-0.836672,"marketCap":112497468},{"date":"2024-12-13","current":-3.581762,"twenty":-5.304506,"median":-1.521983,"eighty":-0.83898,"marketCap":107997569},{"date":"2024-12-20","current":-2.711195,"twenty":-5.205701,"median":-1.533165,"eighty":-0.839527,"marketCap":81748160},{"date":"2024-12-27","current":-2.835561,"twenty":-5.17863,"median":-1.535261,"eighty":-0.840116,"marketCap":85498075},{"date":"2025-01-03","current":-2.959928,"twenty":-5.099036,"median":-1.544275,"eighty":-0.84213,"marketCap":89247991},{"date":"2025-01-10","current":-3.009675,"twenty":-5.079137,"median":-1.548611,"eighty":-0.843908,"marketCap":90747957},{"date":"2025-01-17","current":-2.433608,"twenty":-5.026512,"median":-1.561961,"eighty":-0.844352,"marketCap":73378348},{"date":"2025-01-24","current":-2.259495,"twenty":-5.002846,"median":-1.568227,"eighty":-0.844352,"marketCap":68128466},{"date":"2025-01-31","current":-2.845048,"twenty":-4.983258,"median":-1.583939,"eighty":-0.844352,"marketCap":85784120},{"date":"2025-02-07","current":-2.666247,"twenty":-4.96367,"median":-1.608687,"eighty":-0.845218,"marketCap":80392898},{"date":"2025-02-14","current":-2.397897,"twenty":-4.922363,"median":-1.628712,"eighty":-0.845998,"marketCap":72301580},{"date":"2025-02-21","current":-2.350296,"twenty":-4.891022,"median":-1.682112,"eighty":-0.846132,"marketCap":70866313},{"date":"2025-02-28","current":-2.410095,"twenty":-4.86661,"median":-1.688279,"eighty":-0.846218,"marketCap":72669367},{"date":"2025-03-07","current":-2.472273,"twenty":-4.806327,"median":-1.743561,"eighty":-0.846348,"marketCap":74544185},{"date":"2025-03-14","current":-1.944498,"twenty":-4.734592,"median":-1.77798,"eighty":-0.846348,"marketCap":58630661},{"date":"2025-03-21","current":-2.29139,"twenty":-4.708201,"median":-1.854068,"eighty":-0.847016,"marketCap":69090170},{"date":"2025-03-28","current":-2.4721,"twenty":-4.650258,"median":-1.922414,"eighty":-0.848862,"marketCap":66067138},{"date":"2025-04-04","current":-2.413361,"twenty":-4.59541,"median":-1.944498,"eighty":-0.851037,"marketCap":64497315},{"date":"2025-04-11","current":-2.280106,"twenty":-4.580872,"median":-2.04062,"eighty":-0.852399,"marketCap":60936058},{"date":"2025-04-17","current":-2.903753,"twenty":-4.554582,"median":-2.0535,"eighty":-0.852478,"marketCap":77603098},{"date":"2025-04-25","current":-3.356552,"twenty":-4.454375,"median":-2.076514,"eighty":-0.853044,"marketCap":89704194},{"date":"2025-05-02","current":-2.895026,"twenty":-4.403445,"median":-2.091503,"eighty":-0.854326,"marketCap":77369867},{"date":"2025-05-09","current":-2.509874,"twenty":-4.383857,"median":-2.162715,"eighty":-0.855506,"marketCap":69359282},{"date":"2025-05-16","current":-2.434565,"twenty":-4.364268,"median":-2.198661,"eighty":-0.855879,"marketCap":67278145},{"date":"2025-05-23","current":-2.289789,"twenty":-4.325092,"median":-2.203443,"eighty":-0.857513,"marketCap":63277338},{"date":"2025-05-30","current":-2.003484,"twenty":-4.231068,"median":-2.203443,"eighty":-0.860923,"marketCap":55365428},{"date":"2025-06-06","current":-1.790541,"twenty":-4.21148,"median":-2.198661,"eighty":-0.860923,"marketCap":49480833},{"date":"2025-06-13","current":-2.118396,"twenty":-4.191892,"median":-2.173312,"eighty":-0.861736,"marketCap":58540957},{"date":"2025-06-20","current":-1.829819,"twenty":-4.181356,"median":-2.162715,"eighty":-0.861736,"marketCap":50566254},{"date":"2025-06-27","current":-2.114176,"twenty":-4.142246,"median":-2.121967,"eighty":-0.863916,"marketCap":58424341}],"updateTime":1751146264461}}}